Journal: Heliyon
Article Title: Multi-omic analyses identified SFRP4 as a novel biomarker in abnormal uterine bleeding with ovulatory dysfunction.
doi: 10.1016/j.heliyon.2024.e37168
Figure Lengend Snippet: Fig. 7. Effects of SFRP4 knockdown in hEECs on the Wnt pathway. Expression of SFRP2, Wnt-3A, Wnt-5A, Wnt-7A and Fzd-5 was measured in hEECs transfected with si-NC or si-SFRP4 by western blotting 72 h later. (A) Representative western blots of SFRP2, Wnt-3A, Wnt-5A, Wnt-7A and Fzd-5 in the si-NC and si-SFRP4 groups (n = 4). For the uncropped versions of western blotting, please refer to Supplement Files. (B) Relative densitometric values of SFRP2, Wnt-3A, Wnt-5A, Wnt-7A and Fzd-5 in the si-NC and si-SFRP4 groups. Data are presented as mean ± SD. ns, no significance; *p < 0.05; **p < 0.01.
Article Snippet: Western blotting was conducted as previously done [17] The primary antibodies: rabbit antibody against SFRP4 at dilution 1:1000 (Invitrogen, USA), mouse antibody against GAPDH at dilution 1:10000 (Abcam, UK), rabbit antibody against SFRP2 at dilution 1:1000 (Abcam, UK), rabbit antibody against Wnt-3A at dilution 1:1000 (Cell Signaling, USA), rabbit antibody against Wnt-5A at dilution 1:500 (Abcam, UK), rabbit antibody against Wnt-7A at dilution 1:1000 (Abcam, UK), rabbit antibody against Fzd-5 at dilution 1:1000 (Abcam, UK).
Techniques: Knockdown, Expressing, Transfection, Western Blot